Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration.
Cravens
Grant T
GT
Department of Anesthesiology, Mayo Clinic, 200 First Street, Southwest, Rochester, Minnesota 55905, USA.
Brown
Michael J
MJ
Brown
Daniel R
DR
Wass
C Thomas
CT
D000933:Antifibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002817:Chordoma / Q000601:surgery; D003118:Color Perception / Q000187:drug effects*; D003117:Color Vision Defects / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019635:Neurosurgical Procedures; D013125:Spinal Neoplasms / Q000601:surgery; D013131:Spine / Q000601:surgery*; D014148:Tranexamic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid